FAMAR Health Care Services
- Biotech or pharma, therapeutic R&D
- CMO, CRO
- Other R&D services
Famar is a leading European service provider for the development and production of pharmaceutical and healthcare products CDMO with a legacy of more than 75 years of expertise in the majority of pharmaceutical dosage forms.
In October 2024, MidEuropa, a prominent European private equity firm, completed the acquisition of a controlling stake in FAMAR driven by several strategic objectives: Expansion of R&D and Manufacturing Capabilities, Geographical Growth, Operational Efficiency and Value Addition and Platform for Further Acquisitions.
On May 14th 2025 FAMAR, is pleased to announce the signature of an agreement to acquire a sterile production site in Homburg (Saar), Germany, from MIP Pharma. The acquisition represents a strategic milestone in FAMAR’s growth journey, strengthening its footprint in high-value dosage forms and expanding its capabilities in aseptic and lyophilized fill & finish.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}